Plasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in Thailand

Mahidol University5,181 enrolled

Overview

The investigators assessed the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation.

The investigators aimed to assess the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation. The investigators compared the population between the age groups 12-18 years, 18-45 years and over 45 years to monitor the symptoms of coronavirus patients treated in home isolation and long-term symptoms including factors related to the patient's recovery in the past, present, and future.

Study Type

OBSERVATIONAL

Enrollment

5,181

Conditions

COVID-19

Eligibility

Sex: ALLMin age: 12 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. patient with infected with the novel coronavirus disease 2019 (COVID-19) who has been end of self-quarantine at Siriraj Hospital more than 21 days. 2. Thai nationality, able to read and write Thai language 3. able to use telephone and line to communicate Exclusion Criteria: 1\. people who received additional vaccination after leaving quarantine before the day of the immunization test

Locations (1)

Faculty of Medicine Siriraj Hospital, Mahidol University

Bangkok Noi, Bangkok, Thailand

Outcomes

Primary Outcomes

Anti-SARS-CoV-2 RBD IgG

Anti-RBD IgG (BAU/mL)

Time frame: Baseline

Anti-SARS-CoV-2 NP

Anti-SARS-CoV-2 NP (PRNT50 titer)

Time frame: Baseline

Cycle threshold of the first PCR test

Cycle threshold (Ct)

Time frame: Baseline

Secondary Outcomes

Number of vaccine injection

Time frame: Baseline

Type of vaccine injection

Time frame: Baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.